id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S5924 R15056 |
Artama (Epilepsy) (Controls exposed to Lamotrigine, sick), 2013 | Caesarean section | during pregnancy (anytime or not specified) | population based cohort retrospective | exposed to other treatment, sick excluded | Adjustment: No |
0.34 [0.04;2.69] C excluded (control group) |
1/14 32/173 | 33 | 14 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S5905 R14848 |
Artama (Epilepsy) (Controls unexposed, disease free), 2013 | Caesarean section | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, disease free excluded | Adjustment: Yes |
0.43 [0.06;3.27] excluded (control group) |
1/14 114,791/721,948 | 114,792 | 14 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S5916 R14967 |
Artama (Epilepsy) (Controls unexposed, sick), 2013 | Caesarean section | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, sick | Adjustment: Yes | 0.37 [0.05;2.85] | 1/14 331/1,800 | 332 | 14 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8222 R25751 |
Endo (Epilepsy) (Controls unexposed, disease free), 2004 | Cesarean section | throughout pregnancy | retrospective cohort | unexposed, disease free excluded | Adjustment: No |
7.93 [0.16;402.44] C excluded (control group) |
1/1 74/656 | 75 | 1 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8224 R25781 |
Endo (Epilepsy) (Controls unexposed, sick), 2004 | Cesarean section | throughout pregnancy | retrospective cohort | unexposed, sick | Adjustment: No | no data | 1/1 0/1 | 1 | 1 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 2 studies | NaN [NaN;NaN] | 333 | 15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Epilepsy) (Controls unexposed, sick; 2: Epilepsy) (Controls unexposed, sick;
Funnel plot not drawn. Less than 3 points.
Asymetry test p-value = NaN (by Egger's regression)
not enought points
Funnel plot not drawn. Less than 3 points.
excluded 8222, 5924, 5905